Doximity announced October 29 that it has launched DoseCheck, a verification feature within its Ask clinical decision-support tool.
The company says the feature checks AI-generated medication dosing statements against a structured drug database, using FDA labeling and professional guidelines. It adds a rule-based check rather than asking a language model to evaluate its own answer.
DoseCheck has been rolled out without charge to Ask users on mobile and desktop, according to Doximity’s announcement.
The company described the release alongside internal testing of nine AI models using more than 8,000 dosing questions drawn from physician queries. It reported errors involving newer medicines, patient characteristics and confusion over units or similarly named drugs.
Those findings describe Doximity’s own evaluation. The announcement does not establish independent clinical validation of every output or a guarantee that dosing errors cannot occur.
The product is intended to support medical professionals. This account reports its launch and stated verification method; it does not recommend a medicine, dose or treatment for an individual patient.
Sources: Doximity — October 29 Business Wire Release, Distributed by Nasdaq: https://www.nasdaq.com/press-release/doximity-launches-dosecheck-catch-dangerous-ai-drug-dosing-errors-they-reach-doctors